
Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2WnrOSS
via
IFTTT
0 comments:
Post a Comment